ArticleVaccines2023

A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10-60 Years Following Essen and Zagreb Vaccination Procedures.

Xiaohong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.